Grupo Fleury has acquired the renowned diagnostic brands Bioclínico and Pretti, marking its strategic entry into the Espírito Santo market and further expanding its national presence.

Target Information

The Grupo Fleury recently announced the acquisition of two well-established diagnostic brands in the state of Espírito Santo: Bioclínico and Pretti. This acquisition marks the company's entry into the capixaba market, further enhancing its national reach and complementing its services in Brazil's Southeast region. Over the past five years, Grupo Fleury has invested over R$ 1 billion in acquiring 12 companies, which include a total of 125 service units and generate more than R$ 500 million annually.

Laboratório Pretti operates clinical analyses through 25 service units in the metropolitan area of Greater Vitória. With over 55 years of experience, it has built a solid reputation and strong respect within the medical community and among its clients. For the fiscal year ended December 31, 2020, Pretti reported an audited gross revenue of R$ 53.6 million. The enterprise value for 100% of Pretti in this transaction is set at R$ 193.1 million.

Similarly, Laboratório Bioclínico has been a key player in clinical analyses for 33 years, operating through 15 units in the same metropolitan area. Bioclínico also boasts a strong reputation with the medic